SCOPUS 정보 검색 플랫폼

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 431-441

Hepatitis C advances in antiviral therapy: What is accepted treatment now?

(1) Mchutchison, John G a,b

a SCRIPPS CLINIC (United States)

b SCRIPPS RESEARCH INSTITUTE (United States)

Author keywords

Antiviral therapy; Hepatitis C; Interferon; Ribavarin; Sustained viral response

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; INTERFERON; RIBAVIRIN; VIRUS RNA;

ANEMIA; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFICACY; GENOTYPE; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS LOAD;

EID: 0036091719 PISSN: 08159319 EISSN: None Source Type: Journal
DOI: 10.1046/j.1440-1746.2002.02777.x Document Type: Conference Paper

Times cited : (34)

References (45)

1
- 0032585237
- Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
- International Hepatitis Interventional Therapy group (IHIT)
- (1998) Lancet , vol.352 , pp. 1426-1432
- Poynard, T.¹ Marcellin, P.² Lee, S.S.³

2
- 0032171326
- Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection?
- (1998) Hepatology , vol.29 , pp. 362-368
- McHutchison, J.¹ Blatt, L.² Sedghi-Vaziri, A.³ Russell, J.⁴ Schmid, P.⁵ Conrad, A.⁶

3
- 0032547938
- Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
- Hepatitis Interventional Therapy Group
- (1998) N. Engl. J. Med. , vol.339 , pp. 1485-1492
- McHutchison, J.G.¹ Gordon, S.C.² Schiff, E.R.³

4
- 0032501714
- Randomised, double-blind, placebo controlled trial of interferon alfa-2b with and without ribavirin for chronic hepatitis C
- The Swedish Study Group
- (1998) Lancet , vol.351 , pp. 83-87
- Reichard, O.¹ Norkrans, G.² Fryden, A.³ Braconier, J.H.⁴ Sonnerborg, A.⁵ Weiland, O.⁶

5
- 0030979346
- Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers
- (1997) J. Hepatol. , vol.26 , pp. 961-966
- Schalm, S.W.¹ Hansen, B.E.² Chemello, L.³

6
- 0032731788
- Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C
- (1999) Hepatology , vol.30 , pp. 1318-1324
- Younossi, Z.M.¹ Singer, M.E.² McHutchison, J.G.³ Shermock, K.M.⁴

7
- 0030720484
- Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C
- (1997) Ann. Intern. Med. , vol.127 , pp. 855-865
- Bennett, W.G.¹ Inoue, Y.² Beck, J.R.³

8
- 0034124763
- Cost-effectiveness of 24 or 48 weeks of interferon a-2b alone or with ribavirin as initial treatment of chronic hepatitis C
- (2000) Am. J. Gastroenterol. , vol.95 , pp. 1524-1530
- Wong, J.B.¹ Poynard, T.² Ling, M.-H.³ Albrecht, J.K.⁴ Pauker, S.G.⁵

9
- 0035133564
- The effects of interferon-alpha 2b in combination with ribaravin on health related quality of life and work productivity
- (2001) J. Hepatol. , vol.34 , pp. 140-147
- McHutchison, J.G.¹ Ware J.E., Jr.² Bayliss, M.S.³

10
- 0031704927
- 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C
- (1998) Hepatology , vol.28 , pp. 1121-1127
- Lau, D.T.¹ Kleiner, D.E.² Ghany, M.G.³ Park, Y.⁴ Schmid, P.⁵ Hoofnagle, J.H.⁶

11
- 15644380122
- Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy
- (1997) Ann. Intern. Med. , vol.127 , pp. 875-881
- Marcellin, P.¹ Boyer, N.² Gervais, A.³

12
- 0032934283
- Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
- The Consensus Interferon Study Group
- (1999) Hepatology , vol.29 , pp. 264-270
- Bonkovsky, H.L.¹ Woolley, J.M.²

13
- 0030481064
- Modeling therapeutic benefit in the midst of uncertainty: Therapy for hepatitis C
- (1996) Dig. Dis. Sci. , vol.41
- Bennett, W.G.¹ Pauker, S.G.² Davis, G.L.³ Wong, J.B.⁴

14
- 0030924166
- The role of liver biopsy in hepatitis C
- (1997) Hepatology , vol.26
- Perrillo, R.P.¹

15
- 0032583497
- Pretreatment evaluation of chronic hepatitis C. Risks, benefits, costs
- (1998) JAMA , vol.280 , pp. 2088-2093
- Wong, J.B.¹ Bennett, W.G.² Koff, R.S.³ Pauker, S.G.⁴

16
- 0030976826
- Measuring hepatitis C viremia in clinical samples: Can we trust the assays?
- (1997) Hepatology , vol.26 , pp. 1-4
- Pawlotsky, J.M.¹

17
- 0033839969
- Standardization of hepatitis C virus RNA quantification
- (2000) Hepatology , vol.32 , pp. 654-659
- Pawlotsky, J.M.¹ Bouvier-Alilas, M.² Hezode, C.³ Darthuy, F.⁴ Remire, J.⁵ Dhumeauz, D.⁶

18
- 0030695103
- Prediction of response during interferon alfa 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: A comparison
- (1997) Hepatology , vol.26 , pp. 1640-1645
- Tong, M.J.¹ Blatt, L.M.² McHutchison, J.G.³ Co, R.L.⁴ Conrad, A.⁵

19
- 0031892672
- Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers
- (1998) J. Interferon Cytokine Res. , vol.18 , pp. 75-80
- Blatt, L.M.¹ Tong, M.J.² McHutchison, J.G.³ Russell, J.⁴ Schmid, P.⁵ Conrad, A.⁶

20
- 77957125323
- Therapy of chronic hepatitis C
- TJ Liang, JH Hoofnagle, eds. New York: Academic Press
- (2001) Hepatitis C, Biomedical Research Reports , pp. 203-240
- McHutchison, J.G.¹ Hoofnagle, J.H.²

21
- 0032934283
- Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy
- The consensus Interferon Study Group
- (1999) Hepatology , vol.29 , pp. 264-270
- Bonkovsky, H.L.¹ Woolley, J.M.²

22
- 0032904754
- Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders
- (1999) Ital. J. Gastroenterol. , vol.31 , pp. 130-134
- Brillanti, S.¹ Foli, M.² Di Tomaso, M.³ Grammantieri, L.⁴ Masci, C.⁵ Bolondi, L.⁶

23
- 0029967721
- HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time
- (1996) Science , vol.271 , pp. 1582-1586
- Perelson, A.S.¹ Neumann, A.U.² Markowitz, M.³ Leonard, J.M.⁴ Ho, D.D.⁵

24
- 0000474902
- Multicenter, randomized, controlled trial comparing high dose daily induction interferon plus ribavirin versus standard interferon alfa-2B plus ribavirin
- (2000) Hepatology , vol.32
- Carithers, R.L.¹ Zeuzem, S.² Manns, M.P.³

25
- 0032895782
- Safety of combination interferon alfa-2b/ ribavirin therapy in chronic hepatitis C-relapsed and treatment-naíve patients
- (1999) Sem. Liver Dis. , vol.19 , pp. 67-75
- Maddrey, W.C.¹

26
- 0000150796
- The effect of dose reduction on sustained response in patients with chronic hepatitis C receiving interferon alfa-2b in combination with ribavirin. AASLD, Dallas, TX
- (2000) Hepatology , vol.32
- McHutchison, J.G.¹ Poynard, T.² Harvey, J.³ Garaud, J.-J.⁴ Albrecht, J.K.⁵

27
- 0031952915
- Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminases activity
- (1998) Hepatology , vol.27 , pp. 868-872
- Mathurin, P.¹ Moussalli, J.² Cadranel, J.F.³

28
- 0030886155
- Hepatitis C in asymptomatic blood donors
- (1997) Hepatology , vol.26
- Alter, H.J.¹ Conry-Cantilena, C.² Melpolder, J.³

29
- 0030928695
- Hepatitis C: The clinical spectrum of disease
- (1997) Hepatology , vol.26
- Hoofnagle, J.H.¹

30
- 85005773666
- Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
- (2000) Gastroenterology , vol.118 , pp. 760-764
- Persico, M.¹ Persico, E.² Suozzo, R.³

31
- 0035120818
- Combination of interferon and ribavirin in chronic hepatitis C: Re-treatment of nonresponders to interferon
- (2001) Hepatology , vol.33 , pp. 704-707
- Di Bisceglie, A.M.¹ Thompson, J.² Smith-Wilkaitis, N.³ Brunt, E.M.⁴ Bacon, B.R.⁵

32
- 0032837102
- Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients
- The Multivirc Group
- (1999) Hepatology , vol.30 , pp. 1054-1058
- Benhamou, Y.¹ Bochet, M.² Di Martino, V.³

33
- 0031583763
- Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C
- UK Haemophilia Centre Director's Organisation
- (1997) Lancet , vol.350 , pp. 1425-1431
- Darby, S.C.¹ Ewart, D.W.² Giangrande, P.L.³

34
- 0035112776
- Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
- (2001) Clin. Infect. Dis. , vol.32 , pp. 492-497
- Bica, I.¹ McGovern, B.² Dhar, R.³

35
- 0032801727
- Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: Analysis of individual patient data of six controlled trials
- Eurohep Study Group for Viral Hepatitis
- (1999) Gastroenterology , vol.117 , pp. 408-413
- Schalm, S.W.¹ Weiland, O.² Hansen, B.E.³

36
- 0033965331
- Is an 'a la carte' combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
- (2000) Hepatology , vol.31 , pp. 211-218
- Poynard, T.¹ McHutchison, J.² Goodman, Z.³ Ling, M.H.⁴ Albrecht, J.⁵

37
- 0033766167
- Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C
- (2000) Hepatology , vol.32 , pp. 1131-1137
- Poynard, T.¹ McHutchison, J.² Davis, G.L.³

38
- 0034619946
- Peginterferon alfa-2a in patients with chronic hepatitis C
- (2000) N. Engl. J. Med. , vol.343 , pp. 1666-1672
- Zeuzem, S.¹ Feinman, S.V.² Rasenack, J.³

39
- 0034619980
- Peginter-feron alfa-2a in patients with chronic hepatitis C and cirrhosis
- (2000) N. Engl. J. Med. , vol.343 , pp. 1673-1680
- Heathcote, E.J.¹ Shiffman, M.L.² Cooksley, G.E.³

40
- 17844403232
- A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C
- (2001) Hepatology , vol.34 , pp. 395-403
- Lindsay, K.L.¹ Trepo, C.² Heintges, T.³

41
- 0035934568
- Peginter-feron alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised controlled trial
- (2001) Lancet , vol.358 , pp. 958-965
- Manns, M.P.¹ McHutchison, J.G.² Gordon, S.C.³

42
- 0000268538
- Pegylated (40kDa) interferon alfa-2a in combination with ribavirin: Efficacy and safety results from a phase III, randomized, actively-controlled, multicenter study
- (2001) Gastroenterology , vol.120
- Fried, M.W.¹ Shiffman, M.L.² Reddy, R.K.³

43
- 0032547944
- Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C
- International Hepatitis Interventional Therapy Group
- (1998) N. Engl. J. Med. , vol.339 , pp. 1493-1499
- Davis, G.L.¹ Esteban-Mur, R.² Rustgi, V.³

44
- 0033838850
- Combined treatment of relapse of chronic hepatitis C with high dose a2b interferon and plus ribavirin for 6 or 12 months
- (2000) J. Hepatol. , vol.33 , pp. 456-462
- DiMarco, V.¹ Almasio, P.² Vaccaro, A.³

45
- 12644299637
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis C
- (1997) Hepatology , vol.26 , pp. 780-785
- Shiffman, M.L.¹ Hofmann, C.M.² Thompson, E.B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.